InvestorsHub Logo
Followers 3421
Posts 32269
Boards Moderated 1
Alias Born 07/08/2006

Re: $heff post# 52773

Monday, 03/26/2012 3:31:52 PM

Monday, March 26, 2012 3:31:52 PM

Post# of 97239
MAPP..$17.14 is halted as PDUFA is today. Here was my post from the weekend. Have not been a fan of it which is why I never traded it. Good luck to those holding today. Comments from the weekend. http://bit.ly/GVb1cH

Message in reply to:

MAPP..$16.49 There are too many risks with this FDA PDUFA play on March 26th. The stock is extremely overvalued at a market cap of 500m. The company does not have a SPA for their Phase III clinical studies. There has been one study conducted instead of the usual two. They stated they did in the past but the FDA cannot find it. There has not been an Advisory Panel convened in place of that. This is an inhaled product so it did not go through the scrutiny that inhaled therapies like Adasuve (ALXA) have gone through. There are a lot of fishy circumstances with this company starting with a late filing then the missing SPA. Good luck to those in it.

Sheff's Station...All Aboard...Sign Up Here!

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.